✦ LIBER ✦

Donor Telomere Length Predicts Recipient Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Bone Marrow Failure Syndromes

✍ Scribed by Gadalla, Shahinaz; Wang, Tao; Haagenson, Michael; Spellman, Stephen R.; Lee, Stephanie J.; Williams, Kirsten M.; Wong, Jason Y.; De Vivo, Immaculata; Savage, Sharon A.

Book ID: 122225451
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 188 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.12.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Donor leukocyte infusion for late graft

Donor leukocyte infusion for late graft failure in a patient with severe aplastic anemia after allogeneic bone marrow transplantation

✍ Hashino, S; Kondo, T; Yonezumi, M; Chiba, K; Tsutsumi, Y; Kondo, Y; Tanaka, J; I 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 102 KB

Severe Infections after Unrelated Donor

Severe Infections after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation in Adults: Comparison of Cord Blood Transplantation with Peripheral Blood and Bone Marrow Transplantation

✍ Rocío Parody; Rodrigo Martino; Montserrat Rovira; Lourdes Vazquez; María José Vá 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Blast Percentage Prior to Transplantatio

Blast Percentage Prior to Transplantation Is the Strongest Predictive Factor for Survival After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Patients with Myelodysplastic Syndrome (MDS)

✍ A.M. Jimenez; E.S. Rich; S. Nathan; J. Maciejewski; J.M. Shammo; D. Katz; E. Bra 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Donor Cell–Derived Myelodysplastic Syndr

Donor Cell–Derived Myelodysplastic Syndrome With Ring Chromosome 7 After Allogeneic Hematopoietic Stem Cell Transplant in 2 Patients With Lymphomas as Primary Disease

✍ Hamdi, Amir; Afrough, Aimaz; Muzzafar, Tariq; Popat, Uday R.; Hosing, Chitra M.; 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 954 KB

Predictive Factors for Adverse Outcomes

Predictive Factors for Adverse Outcomes After Use of Donor Cell Infusion (DCI) in Patients with Relapsed Hematological Malignancies Treated with Allogeneic Hematopoietic Cell Transplantation (alloHCT)

✍ N. Bejanyan; B. Bolwell; L. Rybicki; D. Abounader; H. Duong; R. Dean; R. Sobecks 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Bone marrow–derived mesenchymal stem cel

Bone marrow–derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases

✍ Omer N. Koç; Charles Peters; Patrick Aubourg; Shrini Raghavan; Stephanie Dyhouse 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 886 KB